Quick Summary:
In the ever-evolving healthcare industry, staying at the forefront of innovation and technological advancements is pivotal. Investing in up-to-date market intelligence has never been more crucial, with the global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers projected to reach a value of $7.8 billion by 2030. Enhance your understanding of this high-growth market, and gain a competitive edge through our comprehensive market research report.
This exhaustive study covers a broad spectrum of the market including trends, growth drivers, challenges, and opportunities. It provides a detailed analysis of the global and region-specific market performance, with specific attention to the US and rapidly growing Chinese market. Additionally, this report evaluates leading competitors, allowing you to strategize effectively in this dynamic industry landscape. Cap off your experience by availing complimentary updates for one year, alongside access to our digital archives, research platform and more. Stay ahead of the curve with a purchase of this critical market research report.
Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market to Reach $7.8 Billion by 2030
The global market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers estimated at US$4.6 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2022-2030. Hemostats, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Internal Tissue Sealants segment is readjusted to a revised 6.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 11.3% CAGR
The Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 11.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.Select Competitors (Total 44 Featured) -
- Axio Biosolutions Private Limited
- Beacon Senior Advisors
- Chitogen, Inc.
- Corlison Pte. Limited
- Ethicon US LLC
- GELITA MEDICAL
- LifeBond Ltd.
- Tissuemed Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers?
What is the growth rate of the Global Market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers?
What is the forecasted size of the Global Market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers?
Who are the key companies in the Global Market for Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers?
Report Attribute | Details |
---|---|
No. of Pages | 193 |
Published | September 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.6 Billion |
Forecasted Market Value ( USD | $ 7.8 Billion |
Compound Annual Growth Rate | 6.8% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Axio Biosolutions Private Limited
- Beacon Senior Advisors
- Chitogen, Inc.
- Corlison Pte. Limited
- Ethicon US LLC
- GELITA MEDICAL
- LifeBond Ltd.
- Tissuemed Ltd.